Literature DB >> 8990392

Inability of serum myocyte death markers to predict acute cardiac allograft rejection.

C W Wang1, S R Steinhubl, W J Castellani, F Van Lente, D P Miller, K B James, J B Young.   

Abstract

Acute cardiac rejection involves myocyte necrosis. Hence, markers of myocyte death may be useful in diagnosing rejection. Creatine kinase MB, MB isoforms, and troponins I and T were measured in 186 patients undergoing 365 endomyocardial biopsies. No differences were noted with rejection (rejectors vs. nonrejectors: CK=63.8 U/L and 86.6 U/L, P=0.0881; CK MB=2.04 ng/ml and 2.06 ng/ml, P=0.949; troponin T=0.134 ng/ml and 0.0881 ng/ml, P=0.374; troponin I=0.216 ng/ml and 0.707 ng/ml, P=0.357). The time course of troponins T and I levels in rejectors and nonrejectors do not differ with both groups having early elevations. Markers of myocyte death are inadequate predictors of acute rejection in cardiac allografts. The time course of troponins T and I suggests a possible role as prognostic indicators of outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8990392     DOI: 10.1097/00007890-199612270-00046

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  [Biomarker for diagnosis of rejection after heart transplantation].

Authors:  Matthias Frick; Herwig Antretter; Otmar Pachinger; Gerhard Pölzl
Journal:  Herz       Date:  2010-01       Impact factor: 1.443

Review 2.  Elevated Cardiac Troponin to Detect Acute Cellular Rejection After Cardiac Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Zhengyang Liu; Luke A Perry; Jahan C Penny-Dimri; Michael Handscombe; Isabella Overmars; Mark Plummer; Reny Segal; Julian A Smith
Journal:  Transpl Int       Date:  2022-06-08       Impact factor: 3.842

Review 3.  Where, when and how much: regulation of myelin proteolipid protein gene expression.

Authors:  P A Wight; A Dobretsova
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.